GDS Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,374
Closed -$206K – 236
2026
Q1
$206K Sell
2,374
-20
-0.8% -$1.92K 0.01% 194
2025
Q4
$230K Sell
2,394
-44
-2% -$4.27K 0.01% 176
2025
Q3
$232K Buy
2,438
+134
+6% +$12.3K 0.02% 170
2025
Q2
$201K Sell
2,304
-159
-6% -$13.5K 0.01% 170
2025
Q1
$221K Buy
+2,463
New +$220K 0.02% 158
2024
Q4
– Sell
-3,017
Closed -$272K – 174
2024
Q3
$272K Buy
+3,017
New +$254K 0.03% 142
2023
Q1
– Sell
-6,278
Closed -$488K – 115
2022
Q4
$488K Sell
6,278
-1,557
-20% -$126K 0.09% 80
2022
Q3
$633K Sell
7,835
-1,949
-20% -$175K 0.14% 62
2022
Q2
$878K Sell
9,784
-190
-2% -$19.3K 0.2% 57
2022
Q1
$1.08M Sell
9,974
-163
-2% -$17.2K 0.24% 55
2021
Q4
$1.05M Buy
+10,137
New +$1.17M 0.23% 54

Other funds holding MDT

GDS Wealth Management's MDT Position: Q2 2026 in Review

GDS Wealth Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,374 shares — an estimated $206K sold.

GDS Wealth Management first reported a position in MDT in Q4 2021 and held it in 11 quarters. The position peaked at $1.08M in Q1 2022. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • GDS Wealth Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • GDS Wealth Management sold 2,374 Medtronic shares in Q2 2026, an estimated $206K.
  • GDS Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 11 quarters.
  • GDS Wealth Management's Medtronic position peaked at $1.08M in Q1 2022.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.